Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2005
09/15/2005US20050202553 Animal cells and processes for the replication of influenza viruses
09/15/2005US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases
09/15/2005US20050202411 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
09/15/2005US20050202410 Precise efficacy assay methods for active agents inlcluding chemotherapeutic agents
09/15/2005US20050202048 Chlamydia antigens and vaccine uses of the protein
09/15/2005US20050202042 Toxin B repeating units (rBRU) of Clostridium difficile and an antigen of a pathogenic microorganism other than C. difficile; eliciting T-cell dependent and antibody responses
09/15/2005US20050202035 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor
09/15/2005US20050202027 Multivalent compounds for crosslinking receptors and uses thereof
09/15/2005US20050201996 Administering a probiotic to a household pet; contact dermatitis, actinic dermatitis, dermatitis caused by microbial infection, eczema and rosacea
09/15/2005US20050201980 Method for short-term and long-term drug dosimetry
09/15/2005US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201973 Therapeutic supramolecules
09/15/2005US20050201947 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
09/15/2005US20050201946 Intranasal influenza virus vaccine
09/15/2005DE102004009185A1 New hygrophorone derivatives useful as biocides, antibiotics, fungicides, enzyme inhibitors, disinfectants or wood preservatives
09/15/2005CA2559067A1 Influenza virus infection suppressor
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2558586A1 Recombinant varicella-zoster virus
09/15/2005CA2558399A1 Partially loaded antibodies and methods of their conjugation
09/15/2005CA2557989A1 Sulfated oligosaccharide derivatives
09/15/2005CA2557988A1 3-pyridinium methylcephem compound
09/15/2005CA2557571A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients
09/15/2005CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005CA2557301A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005CA2557160A1 Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
09/15/2005CA2556991A1 Crystalline forms of valacyclovir hydrochloride
09/15/2005CA2529752A1 Polypeptide transduction and fusogenic peptides
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574517A1 HCV E1 comprising specific disulfide bridges
09/14/2005EP1574512A1 Polymorphic and other crystalline forms of cis-FTC
09/14/2005EP1574503A1 Novel 2,4-diamino-1,3,5-triazine derivative
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574201A1 Composition of an external dermatological agent
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573003A2 Method for producing transgenic animals using oral gene therapy
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572933A2 Modulation of immune response by non-peptide binding stress response polypeptides
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572743A2 Peptides and their use for the treatment of hiv infections
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572711A1 Anhydrous crystalline azido cytosine hemisulfate derivative
09/14/2005EP1572710A2 Antiviral nucleoside derivatives
09/14/2005EP1572687A1 Antibacterial oxazolidinones
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572648A1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
09/14/2005EP1572243A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent
09/14/2005EP1572220A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata
09/14/2005EP1572201A1 Pharmaceutical compositions of sertaconazole for vaginal use
09/14/2005EP1572186A2 Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
09/14/2005EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/14/2005EP1572108A2 Functional mutations in respiratory syncytial virus
09/14/2005EP1572104A2 Induction of apoptosis by hiv-1 infected monocytic cells
09/14/2005EP1572097A2 Nucleoside derivatives for treating hepatitis c virus infection
09/14/2005EP1572095A2 S-l-2 -deoxynucleosides for the treatment of resistant hbv strains and combination therapies
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572074A2 Stabilized synthetic immunogen delivery system
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1572067A2 Conjugates and compositions for cellular delivery
09/14/2005EP1571909A2 Optimized multi-epitope constructs and uses thereof
09/14/2005EP1515698A4 Liposomes containing biologically active compounds
09/14/2005EP1385834B1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
09/14/2005EP1363651B1 Herbal compositions useful as chemopreventive and therapeutic agents
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP1294373B1 Pharmaceutical disinfectants comprising usnic acid and essential oils
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1274445B1 Use of steroidal alkaloids to reverse multidrug resistance
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP0833933B1 A vector and method for producing influenza hemagglutinin
09/14/2005EP0813543B1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1669183A Method and unit for beam control of antenna array
09/14/2005CN1668741A Production of polyketides and other natural products
09/14/2005CN1668736A GM-negative EHV-mutants without heterologous elements
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668623A Pseudopolymorphic forms of a HIV protease inhibitor
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
09/14/2005CN1668598A Use of chemotherapeutic agents
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668584A Pyrrole derivatives as antimycobacterial compounds
09/14/2005CN1668336A Drug transport and delivery system
09/14/2005CN1668329A 疫苗组合物 Vaccine compositions
09/14/2005CN1668328A Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 1798